Skip Navigation
Search Menu
Find a Doctor


Photo of Dr. Robert Bollinger

Robert Cyril Bollinger, Jr, M.D., M.P.H.

Founding Director, Center for Clinical Global Health Education
Professor of Medicine


Appointment Phone


Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Founding Director, Center for Clinical Global Health Education
  • Associate Director for Medicine, Center for Global Health
  • Director, Johns Hopkins Fogarty India Program
  • Director, IMEC-JHU Partnership
  • Professor of Medicine

Centers & Institutes



The Johns Hopkins Hospital

Appointment Phone: 410-955-1725

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map


HIV/AIDS, Infectious Disease

Research Interests

Global health workforce education and capacity building; Public health; International health; Human immunodeficiency virus (HIV); Tuberculosis; Tropical medicine; Mobile health; Point-of-care diagnostics; India; Ethiopia; Zambia; Uganda; South Africa


Dr. Robert C. Bollinger is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in the Department of International Health at the Bloomberg School of Public Health and in the School of Nursing’s Department of Community-Public Health.

Dr. Bollinger has more than 35 years of experience in international public health, clinical research and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic-resistant infections and other emerging diseases.

He is the founding director of the Johns Hopkins Center for Clinical Global Health Education (CCGHE) and the associate director for medicine of the Center for Global Health.

He also serves as director of both the Johns Hopkins Fogarty India Program—a component of the NIH Fogarty International Center—and the IMEC-JHU Partnership to advance applications in health care.

Under Dr. Bollinger’s leadership of the Fogarty India Program, short-term and degree training has been provided to more than 100 visiting scientists at Johns Hopkins, and in-country training has been provided to more than 2,000 Indian scientists.

His commitment to clinician education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger’s research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; and implementing science research projects to optimize healthcare capacity and delivery in resource-limited settings.

Dr. Bollinger is author of more than 150 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.

He has been invited to participate in public health training programs and expert committees, and has been consulted for his expertise by more than 15 countries.

Dr. Bollinger has served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA) and as a member of the PACHA International Subcommittee, and is a current member of the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety.

Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and their award-winning mobile health platform emocha® in resource-limited settings.

Dr. Bollinger received an undergraduate degree from Haverford College, an M.D. from Dartmouth Medical School and an M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at Johns Hopkins.

He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases. more

    Additional Information

  • Education +


    • Dartmouth Medical School / MD (1984)


    • University of Maryland School of Medicine / Internal Medicine (1987)


    • Johns Hopkins University School of Medicine / Infectious Diseases (1992)


    • American Board of Internal Medicine / Infectious Disease (1992, 2012)
    • American Board of Internal Medicine / Internal Medicine (1988)
  • Research & Publications +

    Research Summary

    Dr. Bollinger is committed to improving the health of people living in resource-limited nations through clinical research, education and leadership training.

    He established and has sustained programs in countries throughout Africa, South and Central America, Southeast Asia and the Middle East. He currently leads the Johns Hopkins team providing technical support to the Medical Education Partnership Initiative (MEPI) in Uganda, where he has worked for more than 15 years.

    In 1991, Dr. Bollinger initiated an ongoing NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Medical College. He has served as principal investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which changed World Health Organization (WHO) guidelines for treatment of infants born to HIV-positive mothers to prevent mother-to-child transmission.

    Selected Publications

    Shivakoti R, Gupta A, Ray JC, Uprety P, Gupte N, Bhosale R, Mave V, Patil S, Balasubramanian U, Kinikar A, Bharadwaj R, Bollinger RC, Persaud D. "Soluble CD14: an independent biomarker for risk of HIV mother-to-child transmission in setting of pre- and post-exposure antiretroviral prophylaxis." J Infect Dis. 2015 Oct 6. pii: jiv479. [Epub ahead of print]

    Chang LW, Nakigozi G, Billioux VG, Gray RH, Serwadda D, Quinn TC, Wawer MJ, Bollinger RC, Reynolds SJ. "Effectiveness of peer support on care engagement and preventive care intervention utilization among pre-antiretroviral therapy, HIV-infected adults in Rakai, Uganda: A randomized trial." AIDS Behav. 2015 Oct;19(10):1742-51. doi: 10.1007/s10461-015-1159-y.

    Sahay S, Deshpande S, Bembalkar S, Kharat M, Parkhe A, Brahme RG, Paranjape R, Bollinger RC, Mehendale SM. "Failure to use and sustain male condom usage: lessons learned from a prospective study among men attending STI clinic in Pune, India." PLoS One. 2015 Aug 13;10(8):e0135071. doi: 10.1371/journal.pone.0135071. eCollection 2015.

    Moran D, Edwardson J, Cuneo CN, Tackett S, Aluri J, Kironji A, Cox J, Carroll B, Lie E, Fofana M, Bollinger RC, Ziegelstein RC, Chen CC. "Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative." Med Educ Online. 2015 Jul 27;20:28632. doi: 10.3402/meo.v20.28632. eCollection 2015.

    Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study team. "Pre-cART elevation of CRP and CD4+ T-cell immune activation associated with hiv clinical progression in a multinational case-cohort study." J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):163-71. doi: 10.1097/QAI.0000000000000696.

    Patil S, Bhosale R, Sambarey P, Gupte N, Suryavanshi N, Sastry J, Bollinger RC, Gupta A, Shankar A. "Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India." AIDS Care. 2011 Dec;23(12):1562-9. doi: 10.1080/09540121.2011.579948. Epub 2011 Jun 28.

    Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ. "Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial." PLoS One. 2010 Jun 2;5(6):e10923. doi: 10.1371/journal.pone.0010923.

    Gupta A, Sane SS, Gurbani A, Bollinger RC, Mehendale SM, Godbole SV. "Stigmatizing attitudes and low levels of knowledge but high willingness to participate in HIV management: a community-based survey of pharmacies in Pune, India." BMC Public Health. 2010 Aug 27;10:517. doi: 10.1186/1471-2458-10-517.

    Suryavanshi N, Mave V, Gupte N, Bhosale R, Sambarey P, Patil S, Sastry J, Bollinger R, Gupta A, Shankar A & The SWEN India Study Team. Contraceptive use and factors associated with postpartum surgical sterilization among HIV-infected women in Pune, India. Journal of HIV/AIDS & Social Services. 2015;14(3):21 Aug [Epub ahead of print] DOI:10.1080/15381501.2014.946548

    Linas BS, Latkin C, Genz A, Westergaard RP, Chang LW, Bollinger RC, Kirk GD. Utilizing mHealth methods to identify patterns of high risk illicit drug use. Drug and Alcohol Dependence. 2015;151:250-7.

    Yang C, Linas B, Kirk G, Bollinger R, Chang L, Chander G, Siconolfi D, Braxton S, Rudolph A, Latkin C. Feasibility and acceptability of smartphone-based ecological momentary assessment of alcohol use among African American men who have sex with men in Baltimore. JMIR mHealth uHealth. 2015 Apr-Jun;3(2):e67. doi: 10.2196/mhealth.4344.

    Gandhi BS, Kulkarni K, Godbole M, Dole SS, Kapur S, Satpathy P, Khatri AM, Deshpande PS, Azad F, Gupte N, Bharadwaj R, Bollinger RC, Gupta A. Dengue and chikungunya co-infection associated with more severe clinical disease than mono-infection. International J. of Healthcare and Biomedical Research. 2015 Apr;3(3).

    Shivakoti R, Yang WT, Gupte N, Berendes S, Rose A, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A; NWCS 319 and PEARLS Study Team. Concurrent anemia and elevated CRP predicts HIV clinical treatment failure, including TB, post-antiretroviral therapy initiation. Clin Infect Dis. 2015 Mar 31. doi: 10.1093/cid/civ265. [Epub ahead of print]

    Mave V, Chandanwale A, Bhosale R, Shere D, Gupte N, Suryavanshi N, Kulkarni V, Kagal A, Bharadwaj R, Joshi S, Bollinger R, Gupta A. Vitamin D deficiency and risk of postpartum tuberculosis among HIV-infected breastfeeding mothers in India. Int J Tuberc Lung Dis. 2015 Mar;19(3):302-4. doi: 10.5588/ijtld.14.0658.

    Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A ACTG PEARLS and NWCS 319 Study Group. C-reactive Protein (CRP), Interferon gamma-inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. eCollection 2015. doi: 10.1371/journal.pone.0117424.

    Linas B, Latkin C, Westergarrd RP, Chang LW, Bollinger RC, Genz A, Kirk GD. Capturing illicit drug use where and when it happens: an ecologic momentary assessment of the social, physical and activity environment of using versus craving illicit drugs. Addiction. 2015 Feb;110(2):315-25. doi: 10.1111/add.12768.

  • Academic Affiliations & Courses +

    Courses and Syllabi

    TIME: Global Health, Genes to Society, February of Year One
    The Johns Hopkins School of Medicine

  • Activities & Honors +


    • David M. Levine Excellence in Mentoring Award, Johns Hopkins University Department of Medicine, 2010
  • Videos & Media +

    Recent News Articles & Media Coverage

    Leveraging Technology for Global Health,” Huffington Post, Nov. 12, 2012

Is This You? Edit Profile